Murray, Christopher W.
Brady, Jennifer J.
Han, Mingqi
Cai, Hongchen
Tsai, Min K. http://orcid.org/0000-0003-4732-4259
Pierce, Sarah E. http://orcid.org/0000-0002-9145-9559
Cheng, Ran http://orcid.org/0000-0002-7617-3018
Demeter, Janos http://orcid.org/0000-0002-7301-8055
Feldser, David M. http://orcid.org/0000-0001-5975-864X
Jackson, Peter K. http://orcid.org/0000-0002-1742-2539
Shackelford, David B. http://orcid.org/0000-0002-8270-898X
Winslow, Monte M. http://orcid.org/0000-0002-5730-9573
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (NIH R01-CA175336, NIH R01-CA207133, NIH R01-CA230919, NIH F32-CA189659, NIH R01-CA208642)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIH 5T32GM007276)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Defense (LCRP W81XWH-18-1-0295)
Article History
Received: 27 June 2021
Accepted: 1 February 2022
First Online: 28 February 2022
Competing interests
: M.M.W. is a founder of, and holds equity in, D2G Oncology, Inc. The authors declare no other competing interests.